FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2104380258> ?p ?o ?g. }

• W2104380258 endingPage "98" @default.
• W2104380258 startingPage "88" @default.
• W2104380258 abstract "Vortioxetine has a beneficial pharmacological profile for reducing anxiety and depression. Recently, a number of randomized, double-blind, placebo-controlled clinical trials (RCTs) of vortioxetine have been conducted in patients with generalized anxiety disorder (GAD); however, the results from GAD RCTs are inconsistent. With an extensive search of databases and clinical trial registries, four published short-term RCTs were identified and included in the present meta-analysis. The mean change in total scores on the Hamilton Anxiety Rating Scale (HAMA) from baseline was the primary endpoint. The secondary endpoints included the response and remission rates, as defined by a ≥50% reduction in HAMA total scores and a ≤7 change in the HAMA total score at the end of treatment. In addition, the mean change in the HAMA total score from baseline in the subgroup with a HAMA total score ≥25 at baseline was included. Vortioxetine was significantly more effective than was placebo, with a standardized mean difference (SMD) of −0.118 (95% CIs, −0.203 to −0.033, P = 0.007). In particular, those with severe GAD (HAMA total score ≥25 at baseline) had a significantly greater benefit from vortioxetine than those without (SMD = −0.338, 95% CIs = −0.552 to −0.124, p = 0.002). The odds ratios (ORs) for vortioxetine for response and remission were 1.221 (95% CIs, 1.027 to 1.452, P = 0.024) and 1.052 (95% CIs, 0.853 to 1.296, P = 0.637), respectively. Discontinuation due to adverse events (AEs) (OR = 1.560, 1.006 to 2.419, p = 0.047) was marginally higher in vortioxetine than placebo treatment, whereas discontinuation due to any reason (OR = 0.971, 0.794 to 1.187, p = 0.771) and inefficacy (OR = 0.687, 0.380 to 1.243, p = 0.215) were not significantly different among treatment groups. Although our results suggest that vortioxetine may have a potential as an another treatment option for GAD (especially for severe GAD), they should be interpreted and translated into clinical practice with caution, as the meta-analysis was based on a limited number of RCTs." @default.
• W2104380258 created "2016-06-24" @default.
• W2104380258 creator A5017929593 @default.
• W2104380258 creator A5018271109 @default.
• W2104380258 creator A5025984426 @default.
• W2104380258 creator A5041007677 @default.
• W2104380258 creator A5062596209 @default.
• W2104380258 creator A5062938278 @default.
• W2104380258 creator A5084299599 @default.
• W2104380258 date "2015-05-01" @default.
• W2104380258 modified "2023-09-29" @default.
• W2104380258 title "Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: A systematic review and meta-analysis" @default.
• W2104380258 cites W1897149844 @default.
• W2104380258 cites W1968630621 @default.
• W2104380258 cites W1968692357 @default.
• W2104380258 cites W1971232085 @default.
• W2104380258 cites W1977566467 @default.
• W2104380258 cites W1980777750 @default.
• W2104380258 cites W1983176528 @default.
• W2104380258 cites W1987560991 @default.
• W2104380258 cites W1988200425 @default.
• W2104380258 cites W1988309578 @default.
• W2104380258 cites W2001782289 @default.
• W2104380258 cites W2004652472 @default.
• W2104380258 cites W2005818204 @default.
• W2104380258 cites W2011606125 @default.
• W2104380258 cites W2012424074 @default.
• W2104380258 cites W2020747520 @default.
• W2104380258 cites W2028756415 @default.
• W2104380258 cites W2035524903 @default.
• W2104380258 cites W2036812642 @default.
• W2104380258 cites W2039786436 @default.
• W2104380258 cites W2042122110 @default.
• W2104380258 cites W2048026164 @default.
• W2104380258 cites W2049546836 @default.
• W2104380258 cites W2061304608 @default.
• W2104380258 cites W2061669920 @default.
• W2104380258 cites W2067743319 @default.
• W2104380258 cites W2069176680 @default.
• W2104380258 cites W2070555238 @default.
• W2104380258 cites W2071338229 @default.
• W2104380258 cites W2071735605 @default.
• W2104380258 cites W2075803126 @default.
• W2104380258 cites W2084152792 @default.
• W2104380258 cites W2084170778 @default.
• W2104380258 cites W2094899584 @default.
• W2104380258 cites W2129162473 @default.
• W2104380258 cites W2131763634 @default.
• W2104380258 cites W2140107414 @default.
• W2104380258 cites W2141232381 @default.
• W2104380258 cites W2147234629 @default.
• W2104380258 cites W2151342351 @default.
• W2104380258 cites W2153262242 @default.
• W2104380258 cites W2156665507 @default.
• W2104380258 cites W2159775540 @default.
• W2104380258 cites W2160070901 @default.
• W2104380258 cites W2160836626 @default.
• W2104380258 cites W2166604344 @default.
• W2104380258 doi "https://doi.org/10.1016/j.jpsychires.2015.02.017" @default.
• W2104380258 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25851751" @default.
• W2104380258 hasPublicationYear "2015" @default.
• W2104380258 type Work @default.
• W2104380258 sameAs 2104380258 @default.
• W2104380258 citedByCount "44" @default.
• W2104380258 countsByYear W21043802582015 @default.
• W2104380258 countsByYear W21043802582016 @default.
• W2104380258 countsByYear W21043802582017 @default.
• W2104380258 countsByYear W21043802582018 @default.
• W2104380258 countsByYear W21043802582019 @default.
• W2104380258 countsByYear W21043802582020 @default.
• W2104380258 countsByYear W21043802582021 @default.
• W2104380258 countsByYear W21043802582022 @default.
• W2104380258 countsByYear W21043802582023 @default.
• W2104380258 crossrefType "journal-article" @default.
• W2104380258 hasAuthorship W2104380258A5017929593 @default.
• W2104380258 hasAuthorship W2104380258A5018271109 @default.
• W2104380258 hasAuthorship W2104380258A5025984426 @default.
• W2104380258 hasAuthorship W2104380258A5041007677 @default.
• W2104380258 hasAuthorship W2104380258A5062596209 @default.
• W2104380258 hasAuthorship W2104380258A5062938278 @default.
• W2104380258 hasAuthorship W2104380258A5084299599 @default.
• W2104380258 hasConcept C118552586 @default.
• W2104380258 hasConcept C126322002 @default.
• W2104380258 hasConcept C142724271 @default.
• W2104380258 hasConcept C15744967 @default.
• W2104380258 hasConcept C168563851 @default.
• W2104380258 hasConcept C197934379 @default.
• W2104380258 hasConcept C203092338 @default.
• W2104380258 hasConcept C204787440 @default.
• W2104380258 hasConcept C27081682 @default.
• W2104380258 hasConcept C2777696351 @default.
• W2104380258 hasConcept C2778034309 @default.
• W2104380258 hasConcept C2778715236 @default.
• W2104380258 hasConcept C2779144063 @default.
• W2104380258 hasConcept C2779177272 @default.
• W2104380258 hasConcept C2780051608 @default.
• W2104380258 hasConcept C558461103 @default.
• W2104380258 hasConcept C71924100 @default.

• next